The Australian radiopharma firm's financial maneuver comes amid its roll out of the first targeted positron emission tomography agent for kidney cancer. 

Now that the company has gained FDA approval for multiple algorithms, Eko Health aims to reach as many patients as possible with its AI-powered devices.

Elon Musk's Neuralink is attracting talent and investors as it moves forward with plans to implant devices into patients who can't use their limbs.

More than 60% of adults in the United States are expected to have at least one form of cardiovascular disease by 2050, according to new data published by the American Heart Association. Fortunately, evidence does suggest that healthier lifestyles are starting to become more common as time goes on.

OCR Director Melanie Fontes Rainer emphasized that patients impacted by the incident “must be notified that their protected health information was breached.”

According to a new proposal, using AI to evaluate CCTA results and quantify plaque buildup is “reasonable and medically necessary” in certain clinical scenarios.

A cardiologist in Billings, Montana, says her new-look practice was designed to reach patients faster and ditch unnecessary red tape. Patients pay an upfront fee, and insurance does not play a role in treatment decisions.

This move represents a pivot of sorts for Edwards; instead of pursuing a spin-off of its critical care business, the company is now doubling down on its commitment to develop new structural heart technologies. BD, meanwhile, says the transaction will deliver significant value.